Protagonist Therapeutics (PTGX) Preferred Shares Issued (2016)
Protagonist Therapeutics' (PTGX) quarterly Preferred Shares Issued came in at $8000.0 in Q2 2016, down 99.96% quarter-over-quarter from $22.5 million in Q1 2016.
Protagonist Therapeutics (PTGX) Preferred Shares Issued (2016) Analysis & Trends
Protagonist Therapeutics has disclosed Preferred Shares Issued across 1 years of filings, most recently posting $8000.0 for Q2 2016.
- Preferred Shares Issued for Q2 2016 came in at $8000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2017 was $8000.0 (changed N/A YoY), and the FY2016 annual result was $22.5 million, up 29.64% from the prior year.
- Preferred Shares Issued came in at $8000.0 for Q2 2016 at Protagonist Therapeutics, down from $22.5 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $22.5 million in Q1 2016 to a low of $8000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Protagonist Therapeutics | 7.35 Bn | 7.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 8,000.00 |
| Jun 30, 2016 | 8,000.00 |
| Mar 31, 2016 | 22.50 Mn |
| Mar 31, 2016 | 22.50 Mn |